202 related articles for article (PubMed ID: 27074576)
1. The effect of celecoxib on tumor growth in ovarian cancer cells and a genetically engineered mouse model of serous ovarian cancer.
Suri A; Sheng X; Schuler KM; Zhong Y; Han X; Jones HM; Gehrig PA; Zhou C; Bae-Jump VL
Oncotarget; 2016 Jun; 7(26):39582-39594. PubMed ID: 27074576
[TBL] [Abstract][Full Text] [Related]
2. Celecoxib inhibits tumor growth and angiogenesis in an orthotopic implantation tumor model of human colon cancer.
Wang L; Chen W; Xie X; He Y; Bai X
Exp Oncol; 2008 Mar; 30(1):42-51. PubMed ID: 18438340
[TBL] [Abstract][Full Text] [Related]
3. Obesity increases tumor aggressiveness in a genetically engineered mouse model of serous ovarian cancer.
Makowski L; Zhou C; Zhong Y; Kuan PF; Fan C; Sampey BP; Difurio M; Bae-Jump VL
Gynecol Oncol; 2014 Apr; 133(1):90-7. PubMed ID: 24680597
[TBL] [Abstract][Full Text] [Related]
4. Cyclin D1 expression and the inhibitory effect of celecoxib on ovarian tumor growth in vivo.
Li W; Jiang HR; Xu XL; Wang J; Zhang J; Liu ML; Zhai LY
Int J Mol Sci; 2010 Oct; 11(10):3999-4013. PubMed ID: 21152316
[TBL] [Abstract][Full Text] [Related]
5. Antitumor and anti-metastatic effects of cyclooxygenase-2 inhibition by celecoxib on human colorectal carcinoma xenografts in nude mouse rectum.
Ninomiya I; Nagai N; Oyama K; Hayashi H; Tajima H; Kitagawa H; Fushida S; Fujimura T; Ohta T
Oncol Rep; 2012 Sep; 28(3):777-84. PubMed ID: 22751903
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of CDK1 by RO-3306 Exhibits Anti-Tumorigenic Effects in Ovarian Cancer Cells and a Transgenic Mouse Model of Ovarian Cancer.
Huang Y; Fan Y; Zhao Z; Zhang X; Tucker K; Staley A; Suo H; Sun W; Shen X; Deng B; Pierce SR; West L; Yin Y; Emanuele MJ; Zhou C; Bae-Jump V
Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569750
[TBL] [Abstract][Full Text] [Related]
7. Everolimus exhibits anti-tumorigenic activity in obesity-induced ovarian cancer.
Guo H; Zhong Y; Jackson AL; Clark LH; Kilgore J; Zhang L; Han J; Sheng X; Gilliam TP; Gehrig PA; Zhou C; Bae-Jump VL
Oncotarget; 2016 Apr; 7(15):20338-56. PubMed ID: 26959121
[TBL] [Abstract][Full Text] [Related]
8. Adenovirus type 5 E1A-induced apoptosis in COX-2-overexpressing breast cancer cells.
Sugimoto T; Bartholomeusz C; Tari AM; Ueno NT
Breast Cancer Res; 2007; 9(4):R41. PubMed ID: 17612393
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms underlying the growth inhibitory effects of the cyclo-oxygenase-2 inhibitor celecoxib in human breast cancer cells.
Basu GD; Pathangey LB; Tinder TL; Gendler SJ; Mukherjee P
Breast Cancer Res; 2005; 7(4):R422-35. PubMed ID: 15987447
[TBL] [Abstract][Full Text] [Related]
10. Celecoxib induced apoptosis against different breast cancer cell lines by down-regulated NF-κB pathway.
Wang G; Li J; Zhang L; Huang S; Zhao X; Zhao X
Biochem Biophys Res Commun; 2017 Aug; 490(3):969-976. PubMed ID: 28666869
[TBL] [Abstract][Full Text] [Related]
11. Antitumor properties of taxol in combination with cyclooxygenase-1 and cyclooxygenase-2 selective inhibitors on ovarian tumor growth in vivo.
Li W; Zhai L; Tang Y; Cai J; Liu M; Zhang J
Oncol Res; 2012; 20(2-3):49-59. PubMed ID: 23193911
[TBL] [Abstract][Full Text] [Related]
12. Apoptotic effect of celecoxib dependent upon p53 status in human ovarian cancer cells.
Song YC; Kim SH; Juhnn YS; Song YS
Ann N Y Acad Sci; 2007 Jan; 1095():26-34. PubMed ID: 17404014
[TBL] [Abstract][Full Text] [Related]
13. Relationship between epidermal growth factor receptor (EGFR) mutation and serum cyclooxygenase-2 Level, and the synergistic effect of celecoxib and gefitinib on EGFR expression in non-small cell lung cancer cells.
Li N; Li H; Su F; Li J; Ma X; Gong P
Int J Clin Exp Pathol; 2015; 8(8):9010-20. PubMed ID: 26464643
[TBL] [Abstract][Full Text] [Related]
14. Increased efficacy of metformin corresponds to differential metabolic effects in the ovarian tumors from obese
Han J; Wysham WZ; Zhong Y; Guo H; Zhang L; Malloy KM; Dickens HK; Huh G; Lee D; Makowski L; Zhou C; Bae-Jump VL
Oncotarget; 2017 Dec; 8(67):110965-110982. PubMed ID: 29340030
[TBL] [Abstract][Full Text] [Related]
15. Cyclooxygenase 2 Promotes Proliferation and Invasion in Ovarian Cancer Cells via the PGE2/NF-κB Pathway.
Zhang X; Yan K; Deng L; Liang J; Liang H; Feng D; Ling B
Cell Transplant; 2019 Dec; 28(1_suppl):1S-13S. PubMed ID: 31822119
[TBL] [Abstract][Full Text] [Related]
16. Selective COX-2 inhibitor (celecoxib) decreases cellular growth in prostate cancer cell lines independent of p53.
Katkoori VR; Manne K; Vital-Reyes VS; Rodríguez-Burford C; Shanmugam C; Sthanam M; Manne U; Chatla C; Abdulkadir SA; Grizzle WE
Biotech Histochem; 2013 Jan; 88(1):38-46. PubMed ID: 23167625
[TBL] [Abstract][Full Text] [Related]
17. COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib.
Grösch S; Tegeder I; Niederberger E; Bräutigam L; Geisslinger G
FASEB J; 2001 Dec; 15(14):2742-4. PubMed ID: 11606477
[TBL] [Abstract][Full Text] [Related]
18. Celecoxib induces apoptosis but up-regulates VEGF via endoplasmic reticulum stress in human colorectal cancer in vitro and in vivo.
Xu B; Wang Y; Yang J; Zhang Z; Zhang Y; Du H
Cancer Chemother Pharmacol; 2016 Apr; 77(4):797-806. PubMed ID: 26931344
[TBL] [Abstract][Full Text] [Related]
19. Selective cyclooxygenase-2 inhibitors inhibit growth and induce apoptosis of bladder cancer.
Gee J; Lee IL; Jendiroba D; Fischer SM; Grossman HB; Sabichi AL
Oncol Rep; 2006 Feb; 15(2):471-7. PubMed ID: 16391871
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of cyclooxygenase-2 in human HepG2, Bel-7402 and SMMC-7721 hepatoma cell lines and mechanism of cyclooxygenase-2 selective inhibitor celecoxib-induced cell growth inhibition and apoptosis.
Liu NB; Peng T; Pan C; Yao YY; Shen B; Leng J
World J Gastroenterol; 2005 Oct; 11(40):6281-7. PubMed ID: 16419156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]